SAM
DPLO

Solaris Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Solaris Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-187
Closed -$5K – 458
2016
Q3 		$5K Buy
+187
New +$6.28K ﹤0.01% 425

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Solaris Asset Management's DPLO Position: Q4 2016 in Review

Solaris Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 187 shares — an estimated $5K sold.

Solaris Asset Management first reported a position in DPLO in Q3 2016 and held it in 1 quarter. The position peaked at $5K in Q3 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

  • Solaris Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
  • Solaris Asset Management sold 187 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $5K.
  • Solaris Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 1 quarter.
  • Solaris Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $5K in Q3 2016.
  • 174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Solaris Asset Management's 13F filing for Q4 2016, filed 25 Jan 2017.